Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trial

Journal:
The Lancet Diabetes & Endocrinology
Published:
DOI:
10.1016/s2213-8587(25)00096-8
Affiliations:
10
Authors:
10
Go to article
Institutions Authors Share
Novo Nordisk, Denmark
3.000000
 0.30
Yokohama City University (YCU), Japan
1.000000
 0.10
Catholic University of Leuven (KU Leuven), Belgium
1.000000
 0.10
Peking University People's Hospital, PKUHSC, China
1.000000
 0.10
Korea University College of Medicine, South Korea
1.000000
 0.10
University of Bari Aldo Moro (UniBA), Italy
1.000000
 0.10
Scripps Health, United States of America (USA)
1.000000
 0.10
India Diabetes Research Foundation (IDRF), India
0.500000
 0.05
Dr A Ramachandran's Diabetes Hospitals, India
0.500000
 0.05
Interested in Clinical Sciences?